Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that argenx received European Commission (EC) approval of …
![VYVGART SC - European Commission Approval](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2023/11/pexels-pixabay-161688.jpg?resize=760%2C427&ssl=1)
![VYVGART SC - European Commission Approval](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2023/11/pexels-pixabay-161688.jpg?resize=760%2C427&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that argenx received European Commission (EC) approval of …